The all-cash deal is expected to be finalized in April 2026. With this divestment of its ambulatory labs, Tennessee-based Community Health Systems said it will be better able to focus on its core patient care business. 

The new proposal to extend expanded subsidies for health plans sold through the Affordable Care Act is being backed by 35 Republicans and Democrats—but as the New York Times points out, it will be hard for the bill to get a floor vote. 

The healthcare industry accounts for close to 30% of global helium consumption, with MRI equipment needs accounting for a significant portion of that figure.

The Hotwire Transseptal Access System includes the Hotwire RF Generator and Hotwire RF Guidewire, giving electrophysiologists the tools they need for left-heart access. 

Remote scanning, mobile operations and telehealth logistics were among some of the week’s most talked about topics. 

Two of the world's leading healthcare companies have partnered on a new treatment option for patients with type 1 diabetes.

All 15 members of the FDA's Circulatory System Devices Panel agreed that more data is required to confirm the new device from Johnson & Johnson MedTech is effective. Will the agency agree with these recommendations? Only time will tell.

HHS’s 340B drug discount program is set to shift to a rebate model on New Year’s Day. But a lawsuit and temporary restraining order filed by the AHA and others may block the change from going live on time. 

The nylon loop on some devices can fail to release while removing polyps. Because of the severe risk to patient health, the FDA has designated this recall a Class I.

Artera, a company that utilizes AI for patient communications, made the announcement while revealing it has achieved $100 million in annual revenue. Its products use AI for follow-ups after patient care, in addition to supporting clinical decisions.